The emergence of stem cell therapy for patients with congenital heart disease.

Item

http://www.wikidata.org/entity/Q42583515

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The emergence of stem cell therapy for patients with congenital heart disease.

@en

The emergence of stem cell therapy for patients with congenital heart disease.

@nl

type

Item

label

The emergence of stem cell therapy for patients with congenital heart disease.

@en

The emergence of stem cell therapy for patients with congenital heart disease.

@nl

prefLabel

The emergence of stem cell therapy for patients with congenital heart disease.

@en

The emergence of stem cell therapy for patients with congenital heart disease.

@nl

P1476

The emergence of stem cell therapy for patients with congenital heart disease.

@en

P2093

Brody Wehman

http://www.w3.org/2001/XMLSchema#string

Sunjay Kaushal

http://www.w3.org/2001/XMLSchema#string

P2860

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

Comparison of shunt types in the Norwood procedure for single-ventricle lesions

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Stem cell therapy for pediatric dilated cardiomyopathy.

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

A strong regenerative ability of cardiac stem cells derived from neonatal hearts.

Interstage mortality after the Norwood procedure: Results of the multicenter Single Ventricle Reconstruction trial.

P304

566-569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1161/CIRCRESAHA.115.305821

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25677515

http://www.w3.org/2001/XMLSchema#string

P921

birth defect

P932

4762023

http://www.w3.org/2001/XMLSchema#string